UK Biotech Co. Seeks To Raise £29M, Delist Shares From AIM
U.K. biotechnology group e-Therapeutics PLC said on Wednesday that it has agreed to raise £28.9 million ($36.7 million) and leave the London Stock Exchange's junior Alternative Investments Market, citing a lack...To view the full article, register now.
Already a subscriber? Click here to view full article